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Abstract
Background: Stapler-assisted hepatectomy has not been well established, as a routine procedure,
although few reports exist in the literature. This analysis assesses the safety and outcome of the method
based on peri-operative data.
Materials and Methods: From February 2005 to December 2006, endo GIA vascular staplers were
used for parenchymal liver transection in 62 consecutive cases in our department. There were 18 (29%)
patients with hepatocellular carcinoma (HCC), 31 (50%) with metastatic lesions and 13 (21%) with benign
lesions [adenoma, focal nodular hyperplasia (FNH), simple cysts]. Twenty-one patients underwent major
resections (33.9%) (i.e. removal of three segments or more) and 41 (66.1%) minor hepatic resections.
Results: Median blood loss was 260 ml. The median total operative time was 150 min and median
transection time was 35 min. No patient required more than 2 days of intensive care unit (ICU) treatment.
The median hospital stay was 8 days. Surgical complications included two (3%) cases of bile leak, two
(3%) cases of pneumonia, two (3%) cases with wound infection and two (3%) cases with pleural effusion.
The peri-operative mortality was zero. In a 30-month median follow-up, all patients with benign lesions
were alive and free of disease. The 3-year disease-free survival for patients with HCC was 61% (57% for
patients with colorectal metastases) and the 3-year survival 72% (68% for patients with colorectal
metastases).
Conclusion: Stapler-assisted liver resection is feasible with a low incidence of surgical complications. It
can be used as an alternative for parenchyma transection especially in demanding hepatectomies for
elimination of the operating time and control of bleeding.
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Introduction
Surgical technique in the era of hepatobiliary surgery affects
the overall operative mortality, as it is directly connected to
intra-operative bleeding.1,2 Various methods and instruments
have been developed for safe and tissue-preserving liver paren-
chyma resection (Cavitron Ultrsonic Surgical Aspirator, Hydro
Jet Cutter, radiofrequency assisted devices, etc).3–10 Vascular
staplers are unique devises offering speed and safety during
liver resection. In addition, its use in dividing hepatic veins and
portal branches during hemihepatectomy minimizes blood
loss.11–14
In this article, we provide prospective acquired data on liver
resection with endo GIA vascular staplers in a single centre,
regarding morbidity, blood loss, transection time, disease-free
survival and long-term outcome. We also address the issue of
negative tumour margin status when stapler technique is used for
hepatectomy.
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Materials and methods
From February 2002 to August 2008, a total of 257 patients under-
went liver resection, in a tertiary referral Hepatobiliary and Pan-
creatic Unit, Agia Olga Hospital, Athens, Greece. From February
2005 to December 2006, 62 consecutive patients had liver resec-
tion using staplers for both extrahepatic vascular control and
parenchyma transection. There were 21 major and 41 minor
hepatectomies performed with the use of endo GIA vascular sta-
plers for a variety of lesions (Table 1). Major hepatectomy was
defined as resection of three or more liver segments. Patient char-
acteristics and treatment applied are presented in Table 1. The
potential for resection was assessed by ultrasound, computed
tomography (CT) scan and sometimes magnetic resonance
imaging (MRI) or MR angiography. Liver function was evaluated
using Child–Pugh classification, liver biochemistry and model for
end-stage liver disease (MELD) score in cirrhotics. All patients in
this cohort were Child grade A and most of them had a MELD
score 9 (Table 1). Ascites, encephalopathy, abnormal bilirubin
level (>2 mg/dl) and portal hypertension were contraindications
for liver resection. Portal hypertension was assessed by both
platelet count as a surrogate marker and CT or Doppler imaging.
Patients with a previous history of variceal bleeding were also
excluded from this study. Resections were performed under low
central vein pressure (CVP) anaesthesia (0–5 mmHg) and the
supervision of two hepatobiliary and pancreas surgeons (S.D.,
Ch.D.). Each patient underwent an intra-operative ultrasound to
define tumour location and relation to the major vascular struc-
tures. Intermittent portal triad clamping was not performed.
During parenchyma transaction, clips, sutures and ligatures were
used selectively in combination with an endo GIA vascular stapler.
Transection time was defined as the duration between the begin-
ning and the end of parenchyma transection. Total operating time
was recorded from the beginning of parenchyma transection until
completion of haemostasis. The amount of blood loss was esti-
mated taking into account the suction volume after subtraction of
rinse fluids. Indication for transfusion was a haemoglobin level
<8 g/dl within 48 h after surgery. Drains were placed in all cases
and remained until the 3rd post-operative day unless bile drainage
or serosanguinous fluid above 500 cc was noted. Microscopic
margins of resection were considered positive if there were
tumour cells present at the tested margins. The presence of cir-
rhosis was evaluated by the Isaak fibrosis score15 and the degree of
steatosis was graded as 0 (no steatosis or <10%) and 1 (steatosis
>10%). Bile leak was defined as more than 50 ml of fluid drainage
with bilirubin above 5 mg/dl.
Surgical technique
Patients were placed in the supine position, prepared and draped
in a sterile fashion. The abdomen was initially explored for
extrahepatic disease through a roof-top incision (with or
without extension in the midline to the xiphoid), a reversed
L-shaped incision from the xiphoid to the tip of the 12th right
rib, or a standard transverse abdominal incision; no thoracoto-
mies were necessary. After some initial mobilization of the fal-
ciform triangular ligament, dissection was carried out to expose
the hepatic veins and the porta hepatis. Short hepatic and
caudate veins from the inferior vena cava (IVC) were clipped,
ligated or divided with the endo GIA vascular stapler (Fig. 1) to
fully mobilize the liver. If haemihepatectomy or extended haemi-
hepatectomy was performed, the appropriate hepatic arterial
branch was divided between ligation with sutures, followed by
division of the portal vein branch with the vascular stapler or via
suture. The appropriate hepatic vein(s) was then divided with
the endo GIA 30-mm vascular stapler (Fig. 2). After the transec-
tional line was marked, the liver capsule was divided with
diathermy. For subsequent dissection of the hepatic parenchyma,
liver tissue was fractured stepwise with a vascular clamp and
subsequently divided with endo GIA 30-mm vascular staplers in
Table 1 Patient characteristics and operational data for stapler-
assisted liver resection
n = 62
Median (range) age (years) 65 (59–76)
Gender ratio (male : female) 41:21
CRM metastasis 28
Post-chemotherapy steatosis (in the specimen) 6
Ovarian metastasis 3
Simple cyst 9
Adenoma 2
Focal nodular hyperplasia 2
HCC (diameter between 2cm and 5cm) 18
Non-cirhotics 4
Cirhotics (grade 2 and 3-by Isaak15) (Child A) 14
MELD9 12
MELD>9 2
Alcohol 4
Hepatitis B 9
Hepatitis C 4
Hepatitis D 1
Hemochromatosis 1
Type resection performed
Right hepatectomy 7
Left hepatectomy 14
Segmental resection 28
Wedge resection 13
Total operation time (min) (median) 150 (105 to 240)
Transection time (min) (median) 35 (25 to 105)
Median hospital stay (days) (range) 8 (6 to 13)
Median ICU stay (days) (range) 0 (0 to 2)
CRM, colorectal metastases; HCC, hepatocellular carcinoma; MELD,
model for end-stage liver disease; ICU, intensive care unit.
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a serial fashion without inflow occlusion (Fig. 3). If necessary,
intra-operative ultrasound was used to guide this dissection. It
is recommended that the thickness of parenchyma to be divided
should not exceed 3 cm. After completed resection, the argon
beam coagulation was applied to stop minor oozing. After hae-
mostasis was secure, easy-flow drains were placed in the sub-
phrenic and subhepatic space and the abdomen was closed.
Using this method of liver resection, no Pringle’s manoeuver or
other vascular control was necessary.
Results
No peri-operative death was documented. Median intra-operative
blood loss was 260 ml (range: 150 to 750 ml), estimated by the
aspirated fluid minus irrigation (Table 2). A blood transfusion was
required in 10 patients; four of which were cirrhotics (Table 2). All
of them had a hostile abdomen from previous operations includ-
ing open cholecystectomy and choledoco-duodenostomy indi-
cated by cholelithiasis and choledoholithiasis. Blood loss in these
cases was mainly as a result of adhesiolysis, before transection of
the liver. Two units of packed red blood cells (RBC) were given
post-operatively (72 h after surgery) to maintain an Hb level
above 8 mg/dl. Our team did not associate blood loss during
transection and liver disease. Mean pre-operative haemoglobin
was 12.5 mg/dl and post-operative was 11.8 mg/dl. The median
transection time was 35 min (range 25 to 105 min) (Table 1). The
median total operating time was 150 min (range 105 to 240 min)
(Table 1). The operative time for parenchymal transection was
primarily affected because of two independent factors: (i) the raw
liver surface (major hepatectomies defined as more than three
segments resected were prolonged with median transection time
45 min and range 35 to 105 min compared with minor liver resec-
tions in which median transaction time was 20 min) and (ii) the
Figure 1 Dividing short hepatic veins with the stapler device
Figure 2 Dividing the vessels of the hepatic pedicle
Figure 3 Use of the stapler for the parenchymal phase of liver
resection
Table 2 Blood loss and transfusion requirements related to stapler-
assisted liver resection
Mean blood loss, ml 500 (range 150 to 750)
Median blood loss, ml 260
Mean transfusion requirements, units 0.32 (0 to 2)
Median transfusion requirement, units 0
Mean pre-operative haemoglobin, g/dl 12.5 (range 10.5 to 15)
Mean discharge haemoglobin, g/dl 11.8 (range 8.9 to 12.5)
Patients required FFP (for INR > 2.0) 8 (12%)
FFP, fresh frozen plasma; INR, International Normalized Ratio.
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underlying liver disease. In cirrhotic patients, transection time was
greater because of the fact that control of the haemorrhage from
the cutting surface was necessary before we could proceed with the
transection. In our study, steatosis because of chemotherapy is not
associated with longer transection time. In fact we note that fatty
infiltration makes liver tissue softer and more susceptible to the
resection process.
All patients had a post-operative increase of liver enzymes
which normalized within 7 days. Serial monitoring of liver func-
tion in the first 7 post-operative days revealed peak serum
aspartate aminotransferase on day 1 (median 230.5 u/l, range 99
to 456 u/l) and day 3 (median 133.04 u/l, range 26 to 173 u/l) with
a rapid decline thereafter by day 7. Median peak post-operative
serum bilirubin level was 1.18 mg/dl (range 0.41 to 1.78 mg/dl) on
the first post-operative day.
Procedure-related complications included two cases of bile
leak, which were managed conservatively and regressed after 5 to
10 days (Table 3). Pleural effusion, pneumonia and wound infec-
tion were also documented and managed conservatively (Table 3).
Resected specimens were carefully examined regarding the
tumour-free margin. The margin in most cases was larger than
10 mm and only in 15 cases ranged from 5 to 10 mm.
The length of hospital stay ranged from 4 to 10 days with a
median value of 7 days. In a median follow-up of 30 months, all
patients operated for benign lesions were alive without signs of
recurrence. In seven patients operated for hepatocellular carci-
noma, recurrent disease was evident between 18 and 32 months
after surgery (3 year disease-free survival: 61%). Five of them died
20 to 32 months after the surgical intervention as a result of
generalized disease (3-year survival: 72%) (Table 4).
Patients operated for colorectal metastases reached a 3-year
disease-free survival of 57% and a 3-year survival of 68%. Five of
them were re-operated for recurrent disease (Table 4).
Regarding metastatic lesions from ovarian carcinoma, the
3-year disease-free survival was 66% and the 3-year survival was
100%, but as a result of the very small cohort (3 patients), solid
results cannot be concluded (Table 4).
Discussion
The use of vascular staplers to divide hepatic veins and portal
branches is considered an achievement that has aided in minimiz-
ing blood loss and thereby reduced the need for inflow occlusion.
Recent publications reporting a number of techniques using
stapling devices in liver surgery showed them to be extraordinarily
useful in the safe ligation of inflow and outflow vessels.5,11,12,16–18
Recently, an ultrasound-directed application of vascular staplers,
to selectively divide major intrahepatic blood vessels for inflow
and outflow control during major liver resection, has been shown
to achieve excellent results, reducing blood loss, warm ischaemia
time and operative time.19 Furthermore, reports of laparoscopic
left lateral segmentectomies performed with stapler and stapled
wedge resections of the liver also showed favourable results.18,20
Staplers have been applied in living donor liver transplantation
with promising results.21 Stapling devices can also be useful in
patients with coagulopathy and in the treatment of complex liver
abscesses.11,12,16,18
Our experience in 62 patients who underwent stapler
hepatectomy shows that this technique for parenchymal dissec-
tion is applicable in a routine clinical setting based on both its
feasibility and safety. In the present non-selective series, both
mortality (0%) and total morbidity (14.5%) were as low as in
a recently published large series of non-selected patients
who underwent liver resection in other high-volume surgical
centres.22–25
Control of operative blood loss is one of the immediate con-
cerns when performing liver resection. Excessive blood loss is
associated with increased peri-operative morbidity and, in cases of
colorectal metastases, a shorter disease-free interval.1,2
In contrast to most series,22–24 we did not routinely apply the
Pringle manoeuvre or other vascular control during resection. In
our cohort, median blood loss was 260 ml during stapler hepate-
ctomy. We consider this to be one of the advantages of stapler-
assisted hepatectomy, as the vessels are sealed before they are
transected. The same principle is in force for biliary structures as
well (bile leak in our cohort: 3%).
Serious blood loss can theoretically occur when the stapler has
sealed only half the diameter of the vessel or after misfire of the
devise although we did not experience such a situation. Even in
Table 3 Morbidity after stapler-assisted liver resection
Complication No. of patients
Pleural effusion 2 (3.2%)
Biliary fistula 2 (3.2%)
Hyperbilirubinemia 1 (1.6%)
Pneumonia 2 (3.2%)
Wound infection 2 (3.2%)
Table 4 Long-term results after stapler hepatectomy
n CRM metastases Ovarian metastases HCC Simple cyst Adenoma FNH
28 3 18 9 2 2
Median follow-up (months) 30 27 32 40 25 22
1-, 3-year disease-free survival (%) 69, 57 100, 66 79, 61 100, 100 100, 100 100, 100
1-, 3-year survival (%) 74, 68 100, 100 83, 72 100, 100 100, 100 100, 100
CRM, colorectal metastases; HCC, hepatocellular carcinoma; FNH, focal nodular hyperplasia.
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this or relevant cases of ongoing bleeding, serious blood loss does
not usually occur because of the fact that stapler-assisted hepatic
resection is completed promptly (median transection time in our
cohort: 35 min) eliminating blood loss during the transaction
phase. More to the point, in cases of difficult parenchymal
transection with ongoing bleeding, the stapler device offers faster
specimen removal giving the surgeon the opportunity to control
the loss of blood from the raw liver surface. The obvious help that
endo-GIA stapler provides, does not replace the specialized
manipulations performed by a specialized HPB surgeon in a spe-
cialized centre.
Another potential danger from the use of staplers in the liver is
tearing a major vein (e.g. right hepatic or vena cava), while placing
the instrument. Usually after encircling of the hepatic vein, the
articulated and rotating Endo-GIA vascular stapler is passed
gently around the hepatic vein to staple and divide it. The thinner
blade of the stapler is inserted in preference to the thicker blade
because the space available is limited. As the thinner blade is not
on the same axis as the instrument, difficulty may be encountered
if the tip of the blade impinges on the liver tissue or on the major
vein wall and tearing of the vein may occur. In order to avoid this
complication, we use a right-angle clamp to grab the thinner blade
and guide its insertion into the space between the liver paren-
chyma and major vein. This technique is also reported by other
centres.26
During stapler-assisted hepatectomy, jamming and consequen-
tial failure to release or misfire with no staplers in the cartridge27
are other unfortunate events which may lead to serious, life-
threatening haemorrhage. Such cases have been documented
sporadically in liver surgery but are lower than 1% (L. H. Blum-
gart, personal communication). The hepatobiliary surgeon must
be prepared to place a vascular clamp to control bleeding if such
an incident occurs.
In our study, blood loss was minimal even after demanding
operations with avoidance of inflow occlusion. Similar values were
reported for blood loss during liver resection with portal triad
clamping or extrahepatic control of the hepatic veins in other
studies.25,28,29 More recent studies reported 750 ml as median
intra-operative blood loss, and about 17% of their patients
required transfusion using a variety of transection devices;
however, 27% of these patients underwent intermittent inflow
clamping during liver resection.24 A further decrease in intra-
operative blood loss can be achieved with selective extrahepatic
division of major blood vessels with staplers before dissection of
the liver parenchyma.19,29 The Pringle manoeuvre itself may be
associated with complications resulting from ischaemic injury of
the remnant liver and from abdominal visceral venous stagna-
tion30 especially in cases of chronic liver disease. Thus avoiding
Pringle parenchyma can be easily transected by means of vascular
staplers with minimal blood loss. In our series blood transfusions
were required in 10 patients (16%). In all situations, two units of
packed RBC were transfused in order for the haemoglobin to be
kept above 8 mg/dl.
Biliary leakage and biliomas were present as major obstacles
after liver resection. While the overall complication rate markedly
decreased, the incidence of bile leakage still frequently occurs. In
our series, a bile leak or bilioma was recorded in 3% of cases,
significantly lower than in other reports.31 This low incidence of
bile leak is in our opinion related to the sealing of all injured bile
ducts some of which might have remained unsealed if the stapler
was not used.
The median transection time in our series was 35 min and the
median total operative time was 150 min (Table 1). For major
hepatectomy a median time of 190 min was required whereas
minor liver resection was as fast as 90 min. The innovative advan-
tage in using staplers is that the procedure is fast, in contrast to
others, such as radio-frequency (RF) or saline-enhanced linear
radiofrequency devices.10,13
A negative tumour margin has been reported to be a serious
factor determining disease-free and long-term survival in malig-
nant lesions.32–35 More to the point with regard to hepatocellular
carcinoma (HCC), it has been reported that for macroscopically
solitary HCC, a resection margin aiming grossly at 2 cm, effica-
ciously and safely decreases the post-operative recurrence rate and
improve survival outcomes when compared with a gross resection
margin aiming at 1 cm, especially for HCC2cm.32 In our cohort,
patients with HCC had 72% 3-year survival, which is comparable
with results reported from other centres when resection32,36,37 or
even transplantation38 is performed. The largest report of resected
patients comes from the Liver Cancer Study Group in Japan,37
which has reported 1-, 3-, 5-, and 10-year survival rates of 85%,
64%, 45%, and 21%, respectively, in 6785 cirrhotic patients
treated using hepatic resection between 1988 and 1999.37 Survival
rates as high as 60% at 5 years may be achieved in Child grade A
patients with well-encapsulated tumours of 2cm in diameter.
Although <10% of patients fit these selection criteria, such results,
obtained in patients with good liver function who underwent
anatomical resection, could be favourably compared with those of
liver transplantation.38–40
Regarding colorectal metastatic lesions, a resection margin less
than 5 mm was associated with a greater risk of recurrence on the
surgical margin, with a lesser rate of overall and disease-free
survival, compared with patients in which the resection margin
was 1 cm or more.33–35 All patients though with microscopical
clear margins from a tumour will benefit from hepatectomy.33–35 A
surgical margin >1 cm can be hard to achieve at times. Surgeons
may need to remove major vascular structures, such as the hepatic
vein, with more liver tissue for an adequate margin. Sometimes
the extent of margin has to be compromised in patients with poor
liver function. Although there is a concern regarding tumour
margin status after stapler hepatectomy, an inadequate margin
(<0.5 cm) was not confirmed in our cohort. More precisely 49
patients had more than a 1-cm negative margin and 13 patients
between 0.5 and 1 cm.
The average treatment costs in our series, bearing in mind that
we used approximately four cartridges for each patient, was in
42 HPB
HPB 2009, 11, 38–44 © 2009 International Hepato-Pancreato-Biliary Association
agreement with those reported by others.14 Schemmer et al.14 in
a recently performed evaluation of the intra-operative costs
[including surgery, anaesthesioloy, blood products and the
average number of endo-GIA vascular staplers (Tyco 030412,
60 cm; Tyco 030403, handset)], the median hospital stay and ICU
stay added up to a total of EUR 11 382. Interestingly enough he
reported that there was a cost-benefit when comparing stapler and
conventional methods of more than EUR 2400 in favour of stapler
hepatectomy.14
Regarding colorectal metastases, our long-term results were
comparable with other centres when resection was performed to
treat similar lesions, although using different technique.34,35,41
Nuzzo et al. reported 3-, 5- and 10-year survival rates to be 54.9%,
37.9%, and 22.9%, respectively.34 In his study, global and surgical
margin recurrence rates increased as the tumour-free margin
decreased (P = 0.01 and P < 0.001, respectively). Supplementary at
univariate analysis, the width of surgical margin (P < 0.001),
transfusion requirement, major hepatectomy, R1 resection,
number of metastases, high pre-operative carcinoembryonic
antigen (CEA) and increasing tumour size (P-value from 0.001 to
0.03) were associated with lesser rates of long-term survival. Rees
et al.35 reported 5- and 10-year cancer-specific survival of 36% and
23%, respectively. In his study, multivariate analysis, revealed
seven risk factors to be independent predictors of poor survival:
number of hepatic metastases >3, node positive primary, poorly
differentiated primary, extrahepatic disease, tumour diameter
5 cm, carcinoembyonic antigen level >60 ng/ml and positive
resection margin. The first six of these criteria were used in a
pre-operative scoring system and the last six in the post-operative
setting. Patients with the worst post-operative prognostic criteria
had an expected median cancer-specific survival of 0.7 years and a
5-year cancer-specific survival of 2%. Conversely, patients with
the best prognostic post-operative criteria had an expected
median cancer-specific survival of 7.4 years and a 5-year cancer-
specific survival of 64%. When tested both predictive models
fitted the data well with no significant differences between
observed and predicted outcomes (P > 0.05).
Conclusion
Stapler hepatectomy is both an effective and safe surgical proce-
dure, but controlled clinical trials are needed to further investigate
and develop this liver resection technique. As treatment costs
become more and more a focus in clinical medicine, novel
methods need to be evaluated not only for patient’s safety but also
for their cost-effectiveness.
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